Celldex Therapeutics sell Wells Fargo & Company
Start price
22.08.23
/
50%
€26.60
Target price
22.08.24
-
Performance (%)
18.80%
End price
23.08.24
€31.60
Summary
This prediction ended on 23.08.24 with a price of €31.60. The prediction closed with a disappointing performance of 18.80%. Wells_Fargo___Compan has a follow-up prediction for Celldex Therapeutics, but this time predicts that Celldex Therapeutics is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | 1.020% | 1.020% | -9.174% |
| iShares Core DAX® | 1,43 % | 2,63 % | 12,46 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % | 1,25 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % | 27,38 % |
| iShares S&P 500 | 1,92 % | 1,16 % | 1,63 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Wells Fargo & Company. They set an "underweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€32.67
20.08.26
20.08.26
6.52%
20.02.26
20.02.26
